The Equation Series
Menu

Healthcare · Profile from Healthcare Research Companion

Privia Health Group, Inc.

The Arlington, Virginia physician-enablement company that lets independent doctors stay independent while joining a single-tax-ID Medical Group in each state, running on one athenahealth EHR and a shared management company, and contracting together for value-based care. Backed by a Goldman Sachs-led ~$400m investment in 2014 and listed on Nasdaq in April 2021, it grew from one Virginia group in 2013 to ~5,400 implemented providers, ~1.5m attributed lives and ~$2.1bn of revenue in 2025. Its defining choice was to take little full risk: it earned money mainly from fee-for-service administration and upside-only or modest-downside shared savings, which let it stay profitable and debt-free while agilon health, Cano Health and VillageMD collapsed or retreated.

At a glance

Founded
Formed November 7, 2007 as a Delaware LLC (Privia Health, LLC); first Medical Group launched in Virginia in 2013
Founders
Jeff Butler (founder and longtime CEO); Dave Rothenberg was president in 2014 (reported). Accounts of co-founders differ (verify)
Headquarters
Arlington, Virginia
Ownership / structure
Wholly owned by Brighton Health Group Holdings (a Goldman Sachs Merchant Banking-led vehicle with Pamplona Capital and others) from 2014 to 2021; Nasdaq: PRVA (IPO April 29, 2021). Goldman-affiliated funds held ~38.9% of Brighton pre-IPO and ~28.7% of Privia's stock before the November 2021 secondary (S-1); sponsors have since sold down (verify current holdings)
Leadership (2026)
Parth Mehrotra, CEO (since July 1, 2023; previously president and COO); Shawn Morris, CEO May 2018–June 2023, then director; David King, board chair (from 2023, verify); David Mountcastle, CFO (verify)
Segment and buyer
Provider enablement / physician organisation. Buyers are independent physicians and health systems that join; payers are commercial plans, Medicare (fee-for-service and the Medicare Shared Savings Program), Medicare Advantage plans and Medicaid plans
Scale
5,380 implemented providers and ~1.54m attributed lives at end-2025; practice collections ~$3.47bn; 2025 revenue $2,122.8m (+22.3%); adjusted EBITDA $125.5m; Medical Groups in 17 markets across 16 states plus DC by mid-2026; Privia reported a presence in 24 states and DC at end-2025 including ACO and Care Partners footprint (company filings)
Capital raised / valuation / market cap
~$400m Goldman-led investment (2014, reported); IPO priced at $23 (top of a raised range), ~$449m gross for the base offering, mostly secondary shares; plus a 4m-share private placement to an Anthem affiliate (~$92m at the IPO price, calculated). Market value ~$2.8bn fully diluted at pricing; peak close ~$49 (June 2021); low ~$16 (May 2024); ~$20–29 range in 2025–26 (reported price data, verify)
Signature moves (incl. failures)
Single-TIN Medical Group model on one EHR (2013); Goldman/Brighton $400m (2014); MSSP ACOs (2014 onward); health-system partnerships (Health First 2019, OhioHealth 2023); Nasdaq IPO and Anthem investment (2021); state-by-state expansion (Montana, North Carolina 2022; Connecticut, Washington, South Carolina 2023; Indiana 2024) and a Delaware exit; CEO succession and first GAAP profit (2023); Arizona entry via IMS (2025); Evolent ACO acquisition (2025); post-IPO share collapse and OIG inquiry into a former affiliate (2026)

10 strategic moves analysed

Each one gets a full strategy file in the companion: context, the decision, the financing, what happened, and the lesson.

  1. 2013

    Single TIN Medical Group Model

    Founding / launch of business model

  2. 2014

    Goldman Brighton 400M Investment

    Funding round / recapitalisation (change of control)

  3. 2014

    MSSP ACO Entry

    Launch / value-based contracting

  4. 2019

    Health First Health System Partnership

    Partnership / market entry (Florida)

  5. 2021

    Nasdaq IPO and Anthem Investment

    IPO (plus strategic private placement)

  6. 2022

    New State Expansion and Delaware Exit

    Expansion (market entries) / reversal (exit)

  7. 2023

    CEO Succession and First Profit

    Leadership change / strategy continuity

  8. 2023

    OhioHealth Partnership

    Partnership / market entry (Ohio)

  9. 2025

    Arizona IMS Entry

    Acquisition / market entry

  10. 2025

    Evolent ACO Acquisition

    Acquisition